A new brain model explored bursts of human brain activity never before studied. The bursts may serve as potential biomarkers for depression, dementia, schizophrenia, and ADHD.
Genetic risk factors for certain mental health disorders may impact people's decisions regarding whether to live in urban areas or rural areas, a new study reports.
Both those with schizophrenia and those with social anhedonia have alterations in the social brain network and a diminished correlation with real-world social network size.
Regular consumption of mushrooms may reduce a person's risk of developing depression, a new study reports.
A new AI algorithm can successfully predict which children with microdeletion of chromosome 22 will develop schizophrenia and other mental health disorders later in life.
Schizophrenia itself is associated with loss of excitation, but hallucinations and other symptoms of the disorder are caused by a loss of synaptic inhibition.
White matter functional connectivity distributions may contribute to working memory and processing speed impairments in schizophrenia.
Researchers find a region of the brain stem called the periaqueductal gray may mediate religiosity and spirituality in humans.
Lower cholesterol levels may put people with schizophrenia at higher risk for violent behaviors, including self-harm and suicide. Researchers say lower cholesterol levels make brain cells less sensitive to serotonin, increasing symptoms of depression, impulsivity, and aggression.
Artificial IntelligenceDeep LearningFeaturedMachine LearningNeuroscienceOpen Neuroscience ArticlesPsychology
··5 min readBlood tests revealed specific epigenetic biomarkers for schizophrenia. Researchers applied machine learning to analyze the CoRSIVs region of the human genome to identify the schizophrenia biomarkers. Testing the model with an independent data set revealed the AI technology can detect schizophrenia with 80% accuracy.
Findings reveal how individual neurons in the thalamus can merge signals coming from different regions of the cortex. The findings could lead to new treatment options for schizophrenia, epilepsy, and other brain disorders where thalamus dysfunction is related to clinical symptoms.
Study reveals how the amygdala plays a role in prepulse inhibition by activating inhibitory neurons in the brain stem of mice. The findings could have positive implications in the development of treatments for schizophrenia, OCD, and other disorders marked with impaired somatosensory gating.
